This Government Contract opportunity from Department Of Defense was posted on May 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Reagents and Maintenance Service for Flow Cytometry Instruments
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Defense Health Agency Contracting Activity intends to award a sole source, firm-fixed-price purchase order contract to Beckman Coulter, Inc. for the supply of reagents, maintenance services, and related equipment necessary for the operation and upkeep of flow cytometry instruments at Madigan Army Medical Center’s Pathology Department. This acquisition is justified under the Federal Acquisition Regulation as only Beckman Coulter can meet the specialized requirements needed for the Government-owned Navios 10 analyzer and TQ Prep workstation. The contract will cover a comprehensive list of specific reagents and related consumables essential for conducting flow cytometry testing, a critical diagnostic tool used to identify white blood cell types and detect infectious, autoimmune, or immunodeficiency conditions. Additionally, the vendor will provide maintenance, service, and training for these instruments to support the Core Laboratory Services at the medical center. Delivery is scheduled on or before September 30, 2027, to the Madigan Army Medical Center in Tacoma, Washington. While this notice is not a request for competitive quotes, interested parties may submit capability statements by June 1, 2026, to prove their ability to fulfill the contract requirements. These statements must include technical, management, and cost information but will only be considered to determine whether to proceed with sole source procurement or open competition. The contracting office emphasizes that telephone requests or offers will not be entertained, and challenges to the sole source determination must be submitted by the specified deadline via email to designated contacts. The contract falls under NAICS code 325413, In-Vitro Diagnostic Substance Manufacturing, reflecting the nature of the products and services involved.
General Info
Agency
NAICS
Place of Performance
WA, 98431, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE PURCHASE ORDER CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES.
The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W), Echo Branch intends to negotiate and award a firm-fixed price purchase order (PO) contract for the provision of all services, materials, and equipment necessary to provide required Reagents and Maintenance Service for Flow Cytometry Instruments for Madigan Armey Medical Center, Pathology Department in accordance with Federal Acquisition Regulation (FAR) 6.302-1 Sole Source acquisitions and FAR RFO 12.102 (a) only one source being available to meet the Government’s needs, to:
Beckman Coulter, Inc
250 Kraemer Blvd
Brea, CA 92821-6232
UEI: Z4DRFM3LMJB8
CAGE: 80740
The North American Industry Classification System (NAICS) code for this requirement is 325413 – In-Vitro Diagnostic Substance Manufacturing; the business size standard is 1,250 (# of employees). The Product Service Code (PSC) is 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits, and Sets. The requirement is for Reagents and Maintenance Service contract for Madigan Armey Medical Center. The items being purchased are reagents and testing materials necessary to perform flow cytometry testing using Government-owned Navios 10 analyzer and TQ Prep workstation, as well as maintenance, service, and training on the analyzers for the Department of Pathology, Core Laboratory Services at Madigan Army Medical Center, Joint Base Lewis-McChord, WA. Flow cytometry is a critical tool used to specifically characterize and identify types of white blood cells, and any alteration in that cell type that may be responsible for the onset of infectious diseases, autoimmune disorders or immunodeficiencies.
Requirement Description Product Number Quantity
Anti-Kappa-FITC (Goat Polyclonal), 2ml ASR C15623 2
Anti-Lambda-PE (Goat Polyclonal), 2ml ASR C15189 2
FMC7-FITC, 1ML, ASR IM1364U 2
MYELORPEROXIDASE-RPE, 2ML, ASR IM3455U 2
7-AAD Viability Dye 150t CE A07704 4
CD1a-APC , 1ML, ASR IM3645 2
Anti-TdT (POOL)-FITC, 1ML, ASR IM3524U 2
CD2-Pacific Blue, 0.5ML ASR B09685 2
CD3-ECD, 1ML, ASR IM2705U 2
CD3-FITC, 2ML, ASR IM1281U 2
CD4-APC-Alexa Fluor 700, 0.5ML ASR B10824 2
CD5-PC5.5, 0.5ML ASR A70203 2
CD7-PC7, 1ML ASR A46526 2
CD10-PC7, 1ML ASR A46527 2
CD11c-APCA700, 50t, ASR B43304 2
CD14-PC7, 1ML ASR A22331 2
CD16-APC, 0.5ML ASR B00845 2
CD19-APC, 1ML, ASR IM2470U 4
CD20-ECD, 1ML, ASR IM3607U 4
CD22-RPE, 2ML, ASR IM1835U 2
CD23-RPE, 2 ML ASR A33099 2
CD25-APC-Alexa Fluor 750, 0.5ML ASR B13979 2
CD26-RPE, 2ML, ASR IM2724 2
CD30-APC, 0.5ML ASR A87939 2
CD33-PC5.5, 0.5ML ASR A70198 2
CD34-APC-Alexa Fluor 750, 0.5ML ASR A89309 2
CD38-APC-Alexa Fluor 700, 0.5ML ASR B23489 2
CD45-Krome Orange, 1ML, AS A96416 4
CD56-PC7, 1ML ASR A51078 2
CD81-Pacific Blue, 0.5ML ASR B19717 2
CD79a-PC5.5, 50t, ASR B42018 2
CD103-FITC, 2ML, ASR IM1856U 2
CD117-ECD, 0.5ML ASR B38307 2
CD123-PC5.5, 0.5ML ASR B20022 2
CD138-PC5.5,0.5ML ASR A98835 2
CD45-FITC/CD56-PE/CD19-ECD/CD3-PC5 6607073 8
TETRA 45/4/8/3 6607013 8
FP,FLOW CHECK PRO IVD 3 X 10 ML KIT A63493 7
ISOFLOW(TM) EPICS SHEATH FL,10 8546859 20
FP, FLOW SET PRO IVD 3 X 10 ML KIT A63492 7
IMMUNO-TROL Low Cells 6607098 6
IMMUNO-TROL Cells 6607077 6
IntraPrep Permeabilization Reagent 50t CE A07802 2
ClearLLab 10C B Cell Tube B96805 15
ClearLLab 10C T Cell Tube B96806 15
ClearLLab 10C M1 Cell Tube B96807 6
ClearLLab 10C M2 Cell Tube B96808 6
PT Navios 3L 10C Service Contract B89707 1
CD57-FITC, 2ML, ASR IM0466U 2
IMMUNOPREP Reagent System 7546999 12
CD8-Pacific Blue, 0.5ML ASR A82791 2
Delivery Location:
MADIGAN ARMY MEDICAL CENTER
Bldg. 9040A Rm. G 3803
Tacoma, 98431
Delivery:
On or before: 9/30/2027
Based on market research and previous acquisition history, it has been determined that Beckman Coulter, Inc
is the only source that can meet the Government’s specialized requirement.
This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.
If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Jason Willey at jason.d.willey.civ@health.mil and Tracy M. Robinson at tracy.m.robinson18.civ@health.mil. The closing date for challenges is no later than 10:00 a.m. (Pacific Time), 1 June 2026
NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.